Article Sidebar
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Oxymatrine inhibits proliferation and migration of breast cancer cells by inhibiting miRNA-188 and upregulating its target gene, PTEN
Abstract
In the earlier published article, it was not indicated that there were authors who contributed equally to the work on the first page. This information is now provided as follows:
Xiaoying Ma and Zijiang Sang contributed equally to this work
New citation: Ma X, Sang Z, Zhang Q, Ma W. Oxymatrine inhibits proliferation and migration of breast cancer cells by inhibiting miRNA-188 and upregulating its target gene, PTEN. Trop J Pharm Res 2021; 20(11):2267-2272 doi: 10.4314/tjpr.v20i11.5 Erratum: 2024; 23(6): 1039 doi: http://dx.doi.org/10.4314/ tjpr.v23i6.15
Earlier citation: Ma X, Sang Z, Zhang Q, Ma W. Oxymatrine inhibits proliferation and migration of breast cancer cells by inhibiting miRNA-188 and upregulating its target gene, PTEN. Trop J Pharm Res 2021; 20(11):2267-2272 doi: 10.4314/tjpr.v20i11.5
